Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bavarian Nordic ADR (BVNRY)

Bavarian Nordic ADR (BVNRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bavarian Nordic ADR Philip Heymans Alle 3 Hellerup G7 2900 DNK

www.bavarian-nordic.com P: 45-3326-8383

Description:

Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 2,055,250
Enterprise Value, $K 1,843,240
Shares Outstanding, K 234,350
Annual Sales, $ 1,025 M
Annual Net Income, $ 214,200 K
Last Quarter Sales, $ 121,060 K
Last Quarter Net Income, $ -16,660 K
EBIT, $ 146,120 K
EBITDA, $ 307,510 K
60-Month Beta 1.67
% of Institutional Shareholders 0.00%
Float, K 234,350
% Float 100.00%
Short Volume Ratio 0.15

Growth:

1-Year Return 24.66%
3-Year Return -40.52%
5-Year Return -15.83%
5-Year Revenue Growth 1,193.13%
5-Year Earnings Growth 316.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 05/08/24
Next Earnings Date 08/28/24
Earnings Per Share ttm 0.98
EPS Growth vs. Prev Qtr -112.50%
EPS Growth vs. Prev Year -128.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 3-1 on 01/20/16

BVNRY Ratios

Ratio
Price/Earnings ttm 9.09
Price/Earnings forward 17.14
Price/Earnings to Growth N/A
Return-on-Equity % 15.54%
Return-on-Assets % 10.90%
Profit Margin % 20.89%
Debt/Equity 0.00
Price/Sales 2.04
Price/Cash Flow 4.57
Price/Book 1.41
Book Value/Share 6.32
Interest Coverage 12.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar